28 Consultants Ltd - 17 Feb 2025 SCHEDULE 13G Report for CytoMed Therapeutics Ltd Ordinary Shares, no par value (GDTC)

Filing Manager: 28 Consultants Ltd
Reporting Manager: 28 Consultants Ltd
Security: CytoMed Therapeutics Ltd Ordinary Shares, no par value
Symbol: GDTC
Shares outstanding: 11,552,664 shares
Disclosed Ownership: 880,313 shares
Ownership: 7.6%
Form type: SCHEDULE 13G
Filing time: 04 Mar 2025, 15:33:20 UTC
Date of event: 17 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
28 Consultants Ltd	7.6%	880,313	880,313	0	/s/ Lin Kuan Liang Nicolas	Lin Kuan Liang Nicolas, Director